Works matching DE "HER2 gene"

Results: 935

HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model.

Published in:

OncoImmunology, 2012, v. 1, n. 9, p. 1, doi. 10.4161/onci.22563

By:

Tam Nguyen-Hoai;
Kobelt, Dennis;
Hohn, Oliver;
Vu, Minh D.;
Schlag, Peter M.;
Dörken, Bernd;
Norley, Steven;
Lipp, Martin;
Walther, Wolfgang;
Pezzutto, Antonio;
Westermann, Jörg

Publication type:

Article

MiR-4728-3p could act as a marker of HER2 status.

Published in:

Cancer Biomarkers, 2015, v. 15, n. 6, p. 807, doi. 10.3233/CBM-150524

By:

Hai Li;
Xin Zhou;
Jun Zhu;
Wenfang Cheng;
Wei Zhu;
Yongqian Shu;
Ping Liu

Publication type:

Article

An alternative and sensitive method based on LCM and Q-PCR for HER2 testing in breast cancer.

Published in:

Cancer Biomarkers, 2014, v. 14, n. 3, p. 129, doi. 10.3233/CBM-130311

By:

Fetica, Bogdan;
Balacescu, Ovidiu;
Balacescu, Loredana;
Rus, Meda;
Berindan-Neagoe, Ioana

Publication type:

Article

Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: A short follow-up.

Published in:

Cancer Biomarkers, 2010, v. 6, n. 2, p. 63, doi. 10.3233/CBM-2009-0119

By:

Samy, Nervana;
Ragab, Halla M.;
Maksoud, Nabila Abd El;
Shaalan, Mohamed

Publication type:

Article

Triple-negative breast cancers and the human mammary epithelial cell hierarchy.

Published in:

Breast Disease, 2011, v. 32, n. 1/2, p. 49

By:

Eng-Wong, Jennifer;
Zujewski, Jo Anne;
Ganesan, Shridar;
Karantza, Vassiliki;
Oza, Jay;
Toppmeyer, Deborah

Publication type:

Article

Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer.

Published in:

Breast Disease, 2011, v. 32, n. 1/2, p. 35, doi. 10.3233/BD-2010-0314

By:

Eng-Wong, Jennifer;
Zujewski, Jo Anne;
Chavez, Kathryn J.;
Garimella, Sireesha V.;
Lipkowitz, Stanley

Publication type:

Article

Current treatment options in triple negative breast cancer.

Published in:

Breast Disease, 2011, v. 32, n. 1/2, p. 99, doi. 10.3233/BD-2010-0314

By:

Eng-Wong, Jennifer;
Zujewski, Jo Anne;
Rodler, Eve;
Korde, Larissa;
Gralow, Julie

Publication type:

Article

Clinical trials in triple negative breast cancer.

Published in:

Breast Disease, 2011, v. 32, n. 1/2, p. 123, doi. 10.3233/BD-2010-0314

By:

Eng-Wong, Jennifer;
Zujewski, Jo Anne;
Reeder-Hayes, Katherine E.;
Carey, Lisa A.;
Sikov, William M.

Publication type:

Article

Molecular profiling of triple negative breast cancer.

Published in:

Breast Disease, 2011, v. 32, n. 1/2, p. 73, doi. 10.3233/BD-2010-0314

By:

Eng-Wong, Jennifer;
Zujewski, Jo Anne;
Ma, Cynthia X.;
Luo, Jingqin;
Ellis, Matthew J.

Publication type:

Article

Epidemiology of triple negative breast cancers.

Published in:

Breast Disease, 2011, v. 32, n. 1/2, p. 5

By:

Eng-Wong, Jennifer;
Zujewski, Jo Anne;
Gierach, Gierach L.;
Burke, Aileen;
Anderson, William F.

Publication type:

Article

Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls.

Published in:

Breast Disease, 2009, v. 30, n. 1, p. 15, doi. 10.3233/BD-2009-0278

By:

Varga, Zsuzsanna;
Mallon, Elizabeth

Publication type:

Article

Expression of erbB Receptors and their Ligands in Breast Cancer: Implications to Biological Behavior and Therapeutic Response.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 63

By:

Bacus, Sarah S.;
Gudkov, Andrei V.;
Esteva, Francisco J.;
Yarden, Yosef

Publication type:

Article

Emerging Antibody-Based HER2 (ErbB-2/neu) Therapeutics.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 113

By:

Krauss, W.C.;
Park, J.W.;
Kirpotin, D.B.;
Hong, K.;
Benz, C.C.

Publication type:

Article

Suppressing HER2/neu-Mediated Cell Transformation by Transcriptional Repressors.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 133

By:

Hung, Mien-Chie;
Wang, Shao-Chun

Publication type:

Article

Anti-HER2 Radioimmunotherapy.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 125

By:

Brechbiel, Martin W.;
Waldmann, Thomas A.

Publication type:

Article

HER2/neu: A Target for Breast Cancer Therapy.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 7

By:

Zwick, Esther;
Wallasch, Christian;
Ullrich, Axel

Publication type:

Article

Biochemistry of HER2 Oncogenesis in Breast Cancer.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 31

By:

Alroy, Iris;
Yarden, Yosef

Publication type:

Article

The Potential of Tyrphostins for the Therapy of Breast Cancer.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 145

By:

Levitzki, Alexander;
Gazit, Aviv

Publication type:

Article

Introduction.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 1

By:

Yarden, Yosef

Publication type:

Article

HER2 as a Predictor of Therapeutic Response in Breast Cancer.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 91

By:

Paik, Soonmyung;
Liu, Edison T.

Publication type:

Article

HER2 Testing: Laboratory, Technical and Clinical Considerations.

Published in:

Breast Disease, 1999, v. 11, n. 1, p. 77

By:

Dressler, Lynn G.;
Thor, Ann D.

Publication type:

Article

The clinical value of radiomics models based on multi-parameter MRI features in evaluating the different expression status of HER2 in breast cancer.

Published in:

Acta Radiologica, 2025, v. 66, n. 6, p. 597, doi. 10.1177/02841851251319110

By:

Liu, Tingting;
Lin, Jialu;
Zhang, Jiulou;
Lou, Jianjuan;
Zou, Qigui;
Wang, Siqi;
Wang, Cong;
Jiang, Yanni

Publication type:

Article

Clinical significance of HER2 overexpression in biliary tract carcinoma ——a meta analysis.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1534005

By:

Xu, Haonan;
Liang, Yuwen;
Tang, Wenqiang;
Yang, Xiongxin;
Du, Xiaobo

Publication type:

Article

A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer.

Published in:

Oncology (08909091), 2008, v. 22, n. 11, p. 1270

By:

Brooks, Gabriel;
Borges, Virginia;
Singh, Meenakshi;
Rabinovitch, Rachel;
Finlayson, Christina;
Elias, Anthony

Publication type:

Article

HER-2 Positivity Rates in Advanced Gastric Cancer: Results From a Large International Phase Ill Trial.

Published in:

2008

By:

Bang, Y.;
Chung, H.;
Sawaki, A.

Publication type:

Abstract

COMPELLING DATA FOR TOMORROW.

Published in:

Oncology (08909091), 2008, p. 16

By:

Marshall, John L.

Publication type:

Article

HER2-Positive Breast Cancer: Remaining Challenges.

Published in:

Oncology (08909091), 2006, v. 20, n. 14, p. 1775

By:

Marcom, P. Kelly;
Verrier, Carmel S.

Publication type:

Article

Optimizing Outcomes in HER2-Positive Breast Cancer: The Molecular Rationale.

Published in:

Oncology (08909091), 2005, v. 19, p. 4

By:

Esteva, Francisco J.;
Pusztai, Lajos

Publication type:

Article

Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique.

Published in:

European Journal of Health Economics, 2014, v. 15, n. 1, p. 93, doi. 10.1007/s10198-013-0459-2

By:

Parkinson, Bonny;
Pearson, Sallie-Anne;
Viney, Rosalie

Publication type:

Article

Tailoring Chimeric Ligands for Studying and Biasing ErbB Receptor Family Interactions.

Published in:

Angewandte Chemie, 2014, v. 126, n. 10, p. 2700, doi. 10.1002/ange.201307869

By:

Krueger, Andrew T.;
Kroll, Carsten;
Sanchez, Edgar;
Griffith, Linda G.;
Imperiali, Barbara

Publication type:

Article

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 2, p. 96, doi. 10.1007/s10147-011-0260-0

By:

Hayashi, Naoki;
Nakamura, Seigo;
Tokuda, Yasuharu;
Shimoda, Yuji;
Yagata, Hiroshi;
Yoshida, Atsushi;
Ota, Hidekazu;
Hortobagyi, Gabriel;
Cristofanilli, Massimo;
Ueno, Naoto

Publication type:

Article

High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 2, p. 131, doi. 10.1007/s10147-011-0269-4

By:

Horio, Akiyo;
Fujita, Takashi;
Hayashi, Hironori;
Hattori, Masaya;
Kondou, Naoto;
Yamada, Mai;
Adachi, Eri;
Ushio, Aya;
Gondou, Naomi;
Sueta, Aiko;
Yatabe, Yasushi;
Iwata, Hiroji

Publication type:

Article

A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 6, p. 615, doi. 10.1007/s10147-010-0093-2

By:

Shigematsu, Hideo;
Nakamura, Yoshiaki;
Tanaka, Kimihiro;
Shiotani, Satoko;
Koga, Chinami;
Kawaguchi, Hidetoshi;
Nishimura, Sumiko;
Taguchi, Kenichi;
Nishiyama, Kenichi;
Ohno, Shinji

Publication type:

Article

Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells.

Published in:

Applied Microbiology & Biotechnology, 2011, v. 91, n. 3, p. 613, doi. 10.1007/s00253-011-3306-3

By:

Sommaruga, Silvia;
Lombardi, Alessio;
Salvadè, Agnese;
Mazzucchelli, Serena;
Corsi, Fabio;
Galeffi, Patrizia;
Tortora, Paolo;
Prosperi, Davide

Publication type:

Article

Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer.

Published in:

Amino Acids, 2016, v. 48, n. 2, p. 487, doi. 10.1007/s00726-015-2102-2

By:

Meng, Xuli;
Li, Yongfeng;
Tang, Hongchao;
Mao, Weimin;
Yang, Hongjian;
Wang, Xiaojia;
Ding, Xianfeng;
Xie, Shangnao

Publication type:

Article

Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.

Published in:

Bioinformatics, 2015, v. 31, n. 22, p. 3666, doi. 10.1093/bioinformatics/btv377

By:

Rahman, Mumtahena;
Jackson, Laurie K.;
Johnson, W. Evan;
Li, Dean Y.;
Bild, Andrea H.;
Piccolo, Stephen R.

Publication type:

Article

Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion.

Published in:

Bioinformatics, 2014, v. 30, n. 21, p. 3036, doi. 10.1093/bioinformatics/btu400

By:

Bollig-Fischer, Aliccia;
Marchetti, Luca;
Mitrea, Cristina;
Wu, Jiusheng;
Kruger, Adéle;
Manca, Vincenzo;
Drăghici, Sorin

Publication type:

Article

Impact of Low HER2 Expression on Neoadjuvant Treatment Response in Early Luminal Breast Cancer.

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 8, p. 4355, doi. 10.21608/zumj.2024.313346.3524

By:

Mohamed, Amrallah A.;
Elfaragy, Ola M.;
Erfan Abdelwahab, Fatma Mohamed;
Abdelrahman, Aziza E.

Publication type:

Article

Concordance of HER2 Expression in Paired Primary and Metastatic Sites of Endometrial Serous Carcinoma and the Effect of Intratumoral Heterogeneity.

Published in:

Journal of Molecular Pathology, 2024, v. 5, n. 3, p. 405, doi. 10.3390/jmp5030027

By:

Yap, Francis Hong Xin;
Wilson, Yancey;
Peverall, Joanne;
Amanuel, Benhur;
Allanson, Ben;
Ruba, Sukeerat

Publication type:

Article

Quantitative Measurement of HER2/neu Oncogene Amplification and p53 Tumor Suppressor Gene Deletion by RT-PCR in Breast Cancer.

Published in:

Experimed, 2023, v. 13, n. 3, p. 257, doi. 10.26650/experimed.1374959

By:

Ulfer, Gozde

Publication type:

Article

Apoptosis-inducing anti-HER2 agents operate through oligomerization-induced receptor immobilization.

Published in:

Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02253-4

By:

Stüber, Jakob C.;
Richter, Christian P.;
Bellón, Junel Sotolongo;
Schwill, Martin;
König, Iwo;
Schuler, Benjamin;
Piehler, Jacob;
Plückthun, Andreas

Publication type:

Article

Parental loss at age birth to 21 years and daughters' breast cancer and tumor characteristics.

Published in:

JNCI Cancer Spectrum, 2025, v. 9, n. 2, p. 1, doi. 10.1093/jncics/pkaf004

By:

Keeler, Corinna;
Krigbaum, Nickilou Y;
Cohn, Barbara;
Cirillo, Piera

Publication type:

Article

Multimodal MRI for Estimating Her-2 Gene Expression in Endometrial Cancer.

Published in:

Bioengineering (Basel), 2023, v. 10, n. 12, p. 1399, doi. 10.3390/bioengineering10121399

By:

Li, Xiwei;
Tian, Shifeng;
Ma, Changjun;
Chen, Lihua;
Qin, Jingwen;
Wang, Nan;
Lin, Liangjie;
Liu, Ailian

Publication type:

Article

Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicin.

Published in:

Journal of Liposome Research, 2019, v. 29, n. 1, p. 53, doi. 10.1080/08982104.2018.1430829

By:

Farasat, Alireza;
Rahbarizadeh, Fatemeh;
Ahmadvand, Davoud;
Ranjbar, Saeed;
Khoshtinat Nikkhoi, Shahryar

Publication type:

Article

Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.

Published in:

ANZ Journal of Surgery, 2018, v. 88, n. 10, p. 982, doi. 10.1111/ans.14773

By:

Sim, Yirong;
Tan, Veronique K. M.;
Sidek, Nur A. B.;
Chia, Daryl K. A.;
Tan, Benita K. T.;
Madhukumar, Preetha;
Yong, Wei Sean;
Wong, Chow Yin;
Ong, Kong Wee

Publication type:

Article

Effect of rapamycin on mRNA expression of IL-8 and CXCR1 in HER2+ breast cancer cells.

Published in:

Turkish Journal of Immunology, 2016, v. 4, p. 62

By:

Şirin, Burcu;
Gedik, Mustafa Emre;
Haznedaroğlu, Elif;
Doğan, Ayşe Lale

Publication type:

Article

Prediction of HER2 status in breast cancer patients based on DCE-MRI imaging features combined Ki-67 and VEGF expression.

Published in:

European Journal of Gynaecological Oncology, 2025, v. 46, n. 2, p. 71, doi. 10.22514/ejgo.2025.022

By:

Zhiliang Huang;
Tingting Qu

Publication type:

Article

Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.

Published in:

Oncology Letters, 2019, v. 17, n. 3, p. 2677

By:

Lu, Xiaolin;
Zhang, Peipei;
Zhu, Yao;
Ye, Dingwei

Publication type:

Article

FGFR1 and HER1 or HER2 co‑amplification in breast cancer indicate poor prognosis.

Published in:

Oncology Letters, 2018, v. 15, n. 6, p. 8206, doi. 10.3892/ol.2018.8423

By:

ChEN, Shinan;
Qiu, Yan;
Guo, PENg;
Pu, Tianjie;
FENg, Ye;
Bu, Hong

Publication type:

Article

ZEB1 is involved in regulating HER2-positive breast cancer radiosensitivity by controlling EMT.

Published in:

Oncology Letters, 2018, v. 15, n. 5, p. 6851, doi. 10.3892/ol.2018.7906

By:

FUSHI HAN;
HUIYUAN ZHU;
JINMING XU;
WEI SHUI;
XIAOLING LU

Publication type:

Article